Cargando…

Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome

OBJECTIVES: The aim of this study was to analyze the clinical efficacy and cytomorphologic changes of colon mucosa following the treatment of patients suffering from irritable bowel syndrome (IBS) with mesalazine (5-aminosalicylic acid [5-ASA]). METHODS: In this controlled, randomized, blind clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorofeyev, Andrey E, Kiriyan, Elena A, Vasilenko, Inna V, Rassokhina, Olga A, Elin, Andrey F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132856/ https://www.ncbi.nlm.nih.gov/pubmed/21753896 http://dx.doi.org/10.2147/CEG.S18381

Ejemplares similares

Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis
por: Zhang, Fen-Ming, et al.
Publicado: (2019)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

Evaluation of the Impact of Some Single-Nucleotide Gene Polymorphisms on the Development of Adenomatous Polyps of the Colon in Patients with Irritable Bowel Syndrome
por: Kyrian, Olena, et al.
Publicado: (2023)

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
por: Leighton, Matthew P, et al.
Publicado: (2013)

Randomised clinical trial and meta‐analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity
por: Castro Tejera, Valeria, et al.
Publicado: (2022)

Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial
por: Tkach, Sergii, et al.
Publicado: (2022)

Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome: Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine
por: Jalanka, Jonna, et al.
Publicado: (2021)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis
por: Baumgartner, Maximilian, et al.
Publicado: (2021)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence
por: Kruis, W., et al.
Publicado: (2017)

Efficacy and safety of lactulose for the treatment of irritable bowel syndrome
por: Chen, Hong-Bin, et al.
Publicado: (2019)

Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
por: Matsumoto, Satohiro, et al.
Publicado: (2020)

Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial
por: Ghadir, Mohammad Reza, et al.
Publicado: (2017)

Efficacy of a Digital Personalized Elimination Diet for the Self-Management of Irritable Bowel Syndrome and Comorbid Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Jactel, Samuel N., et al.
Publicado: (2022)

The neurobiology of irritable bowel syndrome
por: Mayer, Emeran A., et al.
Publicado: (2023)

Hypersensitivity to mesalazine in a patient with inflammatory bowel disease: a case report
por: Cronin, Kevin C, et al.
Publicado: (2009)

Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease.
por: Mulder, C J, et al.
Publicado: (1998)

Is irritable bowel syndrome a dysbiotic bowel syndrome?
por: Benno, Peter, et al.
Publicado: (2015)

Bloating in irritable bowel syndrome
por: Safaee, Azadeh, et al.
Publicado: (2011)

ALEXITHYMIA IN IRRITABLE BOWEL SYNDROME
por: Arun, Priti
Publicado: (1998)

Probiotics and irritable bowel syndrome
por: Korpela, Riitta, et al.
Publicado: (2012)

The epidemiology of irritable bowel syndrome
por: Canavan, Caroline, et al.
Publicado: (2014)

Diet in irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Genetics of irritable bowel syndrome
por: Henström, Maria, et al.
Publicado: (2016)

Epidemiology of irritable bowel syndrome
por: Endo, Yuka, et al.
Publicado: (2015)

Biomarkers of Irritable Bowel Syndrome
por: Kim, Jae Hak, et al.
Publicado: (2017)

Pharmacotherapy for Irritable Bowel Syndrome
por: Camilleri, Michael, et al.
Publicado: (2017)

Irritable Bowel Syndrome and Synbiotics
por: Kim, Soo Young
Publicado: (2019)

Irritable bowel syndrome diagnosis
por: Tyllis, Nick
Publicado: (2019)

Irritable bowel syndrome and diet
por: Portincasa, Piero, et al.
Publicado: (2017)

Postinfection Irritable Bowel Syndrome
por: Ghoshal, Uday C
Publicado: (2022)

Irritable Bowel Syndrome and Antidepressants
por: Curtiss, Frederic R.
Publicado: (2008)

Irritable Bowel Syndrome and Resilience
por: Fadgyas Stanculete, Mihaela, et al.
Publicado: (2023)

Irritable Bowel Syndrome: The role of the Psychiatry
por: Fraga, A., et al.
Publicado: (2022)

Biopsychosocial Model of Irritable Bowel Syndrome
por: Tanaka, Yukari, et al.
Publicado: (2011)

No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls
por: Dlugosz, Aldona, et al.
Publicado: (2015)

Irritable Brain Caused by Irritable Bowel? A Nationwide Analysis for Irritable Bowel Syndrome and Risk of Bipolar Disorder
por: Liu, Chia-Jen, et al.
Publicado: (2015)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients
por: Andrae, David A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9b4ao9sj9p8msitbtoit7p3dl9